Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Informa Connect

  1. Events
  2. Organisers
  3. Informa Connect
Events from this organiser
Today

Basel

Tides Europe 2025

The TIDES Europe conference agenda is designed with scientific tracks that delve into comprehensive discovery, development, and manufacturing strategies. These sessions will explore emerging trends [...]

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2025 | Hlx Life Sciences

Site by theLEAP

Go to Top